Altimmune, Inc. (ALT)

3.465 +0.06 (+1.91%) USD  |  NASDAQ  |  Apr 22, 16:00
2.95 -0.52 (-14.86%) After-Hours: 16:45
More

Altimmune Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for ALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Amgen, Inc. Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade
CorMedix, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade